MedPath
HSA Approval

APO-DOXY-TABS 100 mg

SIN08445P

APO-DOXY-TABS 100 mg

APO-DOXY-TABS 100 mg

November 24, 1995

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01AA02

doxycycline

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

DOXYCYCLINE HYCLATE EQV DOXYCYCLINE

100 mg

Doxycycline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-DOXY-TABS 100 mg - HSA Approval | MedPath